TMEM52B and esophageal squamous cell carcinoma: To define whether the oncogenic functions of C12orf59 relies on increased YAP activity, we used verteporfin (VP), a YAP inhibitor, which restrains YAP activity by destroying YAP-TEADs interaction (32), to treat ESCC cells.